Amy Clack executes 10b5-1 sale of 1,677 shares (TW)
Rhea-AI Filing Summary
Issuer Form 144 shows a planned sale by Amy Clack via a 10b5-1 plan. The filing lists a sale of 1,677 shares of Common Stock on 02/10/2026 for $192,318.36. The filing also lists 271 Restricted Stock Units tied to 03/17/2026.
Positive
- None.
Negative
- None.
Insights
Insider executed a planned 10b5-1 disposition; magnitude is modest.
The filing records a 10b5-1 sale by Amy Clack of 1,677 shares on 02/10/2026 with proceeds of $192,318.36. The reported amount is a specific, executed disposition under a pre-arranged plan.
Filing also lists 271 Restricted Stock Units associated with 03/17/2026. Cash‑flow treatment and whether the RSUs represent an additional market sale are not detailed in the provided excerpt; subsequent reports would clarify execution or settlement details.
FAQ
What did Amy Clack report in the Form 144 for TW?
How many shares were sold under the 10b5-1 plan in the TW filing?
Does the Form 144 for TW list any Restricted Stock Units?
Was the sale by Amy Clack an open‑market trade or pre‑arranged?